Uplizna
Uplizna
Uplizna is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive.
Neuromyelitis optica spectrum disorder (NMOSD) is an unpredictable autoimmune disease. The condition is caused by inflammation in the central nervous system, which is made up of the optic nerve, brain stem and spinal cord. Without treatment, continued inflammation can lead to severe attacks that can result in permanent disability.
Uplizna is proven to reduce relapses that may lead to permanent disability.
Administration Information
Uplizna is the only twice-yearly treatment for neuromyelitis optica spectrum disorder (NMOSD). The treatment is administered with 90-minute intravenous (IV) infusions twice a year (after initial two start-up doses).
Potential Side Effects
The most common side effects include urinary tract infection and joint pain. Uplizna may cause serious side effects, including infusion reactions, infections, Hepatitis B virus (HBV) reactivation, Progressive Multifocal Leukoencephalopathy (PML), Tuberculosis (TB), and low blood cell counts. Before starting treatment with Uplizna, your healthcare provider will do blood tests to check for hepatitis B viral infection and tuberculosis.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Uplizna website.
Patient Forms
Before you attend your first appointment at Omega Health, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!
Patient Consent Form
Print & Sign
HIPAA Privacy Authorization Form
Print & Sign
Notice of Privacy Practice
Read
Patient Rights and Responsibilities
Read
Appointment Lateness and Cancelation
Read
